297 related articles for article (PubMed ID: 15214742)
1. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
[TBL] [Abstract][Full Text] [Related]
2. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
3. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
4. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
5. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
[TBL] [Abstract][Full Text] [Related]
6. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
7. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
8. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
[TBL] [Abstract][Full Text] [Related]
9. Management of patent ductus arteriosus in preterm infants.
Ekici F; Atasay B; Günlemez A; Naçar N; Tutar E; Atalay S; Eyileten Z; Uysalel A; Arsan S
Anadolu Kardiyol Derg; 2006 Mar; 6(1):28-33. PubMed ID: 16524797
[TBL] [Abstract][Full Text] [Related]
10. Continuous indomethacin infusion may be less effective than bolus infusions for ductal closure in very low birth weight infants.
de Vries NK; Jagroep FK; Jaarsma AS; Elzenga NJ; Bos AF
Am J Perinatol; 2005 Feb; 22(2):71-5. PubMed ID: 15731984
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
Itabashi K; Ohno T; Nishida H
J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
[TBL] [Abstract][Full Text] [Related]
12. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral and intravenous indomethacin in preterm infants.
Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M
Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile and management of symptomatic patent ductus arteriosus in premature infants.
Shenoi A; Narang A; Bhakoo ON; Bidwai PS
Indian Pediatr; 1991 Feb; 28(2):125-30. PubMed ID: 2055626
[TBL] [Abstract][Full Text] [Related]
16. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study.
Baenziger O; Waldvogel K; Ghelfi D; Arbenz U; Fanconi S
Klin Padiatr; 1999; 211(6):438-41. PubMed ID: 10592922
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
Heo MJ; Lee OS; Lim SC
Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
[TBL] [Abstract][Full Text] [Related]
18. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
[TBL] [Abstract][Full Text] [Related]
19. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
[TBL] [Abstract][Full Text] [Related]
20. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
